Use of generics would save money, study finds

JAMA Internal Medicine study finds public bears "unnecessary expense" when branded drugs are used

WASHINGTON — A new study indicates that the public bears "unnecessary expense" when generic drugs aren't used.

The study, published Monday in JAMA Internal Medicine, found that prescribing branded drugs when generics are available "generates unnecessary medical expenditures, the costs of which are borne by the public in the form of higher copayments, increased health insurance costs, and higher Medicare and Medicaid expenses," the authors, led by Harvard Medical School professor Eric Campbell, wrote.

"The JAMA Internal Medicine study demonstrates that we are still leaving savings on the table that could be achieved by increasing the use of generic drugs," said Ralph Neas, president and CEO of the Generic Pharmaceutical Association, an industry lobbying group. "The use of safe and effective generic versions of brandname drugs currently saves consumers and the U.S. healthcare system $1 billion every other day, a total of $192 billion in 2011. But, as significant as these savings are, there still is room for improvement, and we must realize that generics are part of the solution to sustaining affordable healthcare in America."


Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter. 

Recommended stories

Comments

- 10:53 PM
jhonson101 says

I actually agree with this
I actually agree with this study. Some of the Doctors prescribed those expensive medicine where in there are generics available. how about those poor people who has limited money, how can they afford such expensive medicine. I hope Doctor's could be able to find solution for this, try to considers those poor family.

- 8:47 AM
jacek says

You and me both... it was a
You and me both... it was a very interesting study by the way. Poor people shouldn't suffer like that when it comes to health.

Login or Register to post a comment.